News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medifacts International Inks $1.6 Million Diabetes Study with Top Five Pharmaceutical Company


11/24/2009 10:30:37 AM

ROCKVILLE, Md. & LANGENFELD, Germany--(BUSINESS WIRE)--MEDIFACTS INTERNATIONAL, INC. one of the largest global providers of noninvasive cardiac diagnostic services today announced the award of a $1.6 million contract with a top five pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large, late-stage clinical trial.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES